Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

PolarityTE Inc (PTE) USD0.001

Sell:$0.67 Buy:$0.68 Change: $0.0433 (6.68%)
NASDAQ:0.92%
Market closed |  Prices as at close on 27 November 2020 | Switch to live prices |
Sell:$0.67
Buy:$0.68
Change: $0.0433 (6.68%)
Market closed |  Prices as at close on 27 November 2020 | Switch to live prices |
Sell:$0.67
Buy:$0.68
Change: $0.0433 (6.68%)
Market closed |  Prices as at close on 27 November 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

PolarityTE, Inc., formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. The Company's PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. The Company focuses on various products, including SkinTE, OsteoTE, AngioTE, MyoTE, CartTE, AdiposeTE and NeuralTE. The Company, through SkinTE, is focused on supplying an autologous construct to regenerate a patient’s skin due to a variety of injuries and conditions.

Contact details

Address:
1960 S. 4250 West
SALT LAKE CITY
84104
United States
Telephone:
+1 (385) 2372279
Website:
https://www.polarityte.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PTE
ISIN:
US7310941080
Market cap:
$25.44 million
Shares in issue:
39.24 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Peter Cohen
    Independent Chairman of the Board
  • Richard Hague
    President, Chief Operating Officer
  • David Seaburg
    Chief Executive Officer, Director
  • Jacob Patterson
    Interim Chief Financial Officer
  • Cameron Hoyler
    General Counsel, Secretary, EVP - Corporate Development & Strategy

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.